Healthcare - Biotechnology - NASDAQ - US
$ 0.043
3.61 %
$ 2.34 M
Market Cap
-0.09
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
100.00%
Net Income
Estimate
41.14%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Galera Therapeutics, Inc.
GRTX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart GRTX
EBIT FORECAST
EBIT Forecast Chart GRTX
NET INCOME FORECAST
Net Income Chart GRTX